Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): an overview of Presentation and Pathogenesis and Guidelines for Pathological Diagnosis and Management.

Jones, J Louise and Hanby, Andrew M and Wells, Clive and Calaminici, Maria and Johnson, Laura and Turton, Philip and Deb, Rahul and Provenzano, Elena and Shaaban, Abeer and Ellis, Ian and Pinder, Sarah (2019) Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): an overview of Presentation and Pathogenesis and Guidelines for Pathological Diagnosis and Management. Histopathology. ISSN 1365-2559. This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs

Full text not available from this repository.
Official URL: https://onlinelibrary.wiley.com/doi/abs/10.1111/hi...

Abstract

BACKGROUND

Breast implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is an uncommon complication associated largely with textured implants. It is important that the symptoms associated with BIA-ALCL are recognized and that robust pathways are in place to establish the diagnosis. The aim of this paper is to review what is known of the incidence of the disease, current thoughts on pathogenesis, patterns of presentation, and pathological features to provide standard guidelines for its diagnosis.

METHODS

Systematic review of the literature via PubMed covering cases series, modes of presentation, cytological, histological and immunohistochemical features, and disease outcome.

RESULTS

Since 1997, 518 cases across 25 countries have been registered on the American Society of Plastic Surgeons PROFILE registry, with an estimated risk for women with an implant of 1-3 per million per year. It most frequently presents as a late onset accumulation of seroma fluid, sometimes as a mass lesion. The neoplastic cells are highly atypical consistently strongly positive for CD30, with 43-90% also positive for EMA, and all are ALK-negative. Behaviour is best predicted using a staging system for solid tumours.

CONCLUSION

BIA-ALCL is a rare but important complication of breast implants. Whilst characterised by CD30 positive neoplastic cells, this must be interpreted with care, and we provide pathological guidelines for the robust diagnosis of this lesion, as well as the most appropriate staging system and management strategies. Finally, in order to generate more accurate data on incidence, we recommend mechanisms for the routine central reporting of all cases. This article is protected by copyright. All rights reserved.

Item Type: Article
Additional Information: This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs
Subjects: WH Haemic and lymphatic systems. Haematology
WP Gynaecology. Women’s health
Divisions: Clinical Support > Pathology
Related URLs:
Depositing User: Mrs Yolande Brookes
Date Deposited: 07 Jun 2019 12:51
Last Modified: 07 Jun 2019 12:51
URI: http://www.repository.heartofengland.nhs.uk/id/eprint/2144

Actions (login required)

View Item View Item